FDA DEVICE FACTS
SD LipidoCare Professional System, SD LipidoCare Home System, SD LipidoCare BT Professional System, SD LipidoCare BT Home System
Sd Biosensor
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
(glucose test system) For the quantitative measurement of glucose in capillary whole blood. The glucose testing system is for use by people with diabetes at home as an aid to monitor the effectiveness of diabetes control Same Not applicable Detection Method (lipid test system) Colorimetric Not applicable Same Detection Method (glucose test system) Electrochemical Same Not applicable Hematocrit TC, TG, HDL: 30-52% Glucose: 20-60% Same for glucose TC, TG, HDL: 30- 45%
K. Standard/Guidance Document Referenced (if applicable): CLSI EP05-A2, Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition CLSI EP6-A, Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach, Approved Guideline. CLSI EP07-A2, Interferences Testing in Clinical Chemistry; Approved Guideline-Second Edition. ISO 23640:2011, In vitro diagnostic medical devices-Evaluation of stability of in vitro diagnostic reagents. ISO 14971:2007, Medical Devices-Application of Risk Management to Medical Devices
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。